New hope for leukemia patients out of treatment options
Disease control
Not yet recruiting
This study is testing a new drug called TGRX-678 for adults with chronic phase chronic myeloid leukemia (CML) who have not responded well to or could not tolerate at least three standard treatments. The trial will compare TGRX-678 against other standard leukemia drugs chosen by d…
Phase: PHASE3 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC